A case of neuromyotonia in Behçet disease during TNF-α antagonist therapy.
Neurology Unit, Department of Medical, Surgical and Health Sciences, Azienda Ospedaliero-universitaria Ospedali Riuniti, University of Trieste, Strada di Fiume, 447, 34100, Trieste, Italy, marco.belluzzo@hotmail.com.
Marco
M
Belluzzo
Massimo
M
Dozzo
Erika
E
Pigatto
Franco
F
Schiavon
Fabrizio
F
Monti
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects; D001528:Behcet Syndrome / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D020386:Isaacs Syndrome / Q000150:complications* / Q000175:diagnosis*; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; C529000:golimumab; D000069285:Infliximab